![Venkatesh Locharla Murthy, MD, PHD, F.A.C.C. Venkatesh Locharla Murthy, MD, PHD, F.A.C.C.](/-/media/Non-Clinical/Images/System-Images/Profile-Images/M/Murthy_VenkateshLocharla.png)
General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Ionetix(SIGNIFICANT) EQUITY INTERESTS/STOCK OPTIONS: Abbott Laboratories(SIGNIFICANT), AbbVie, Inc.(SIGNIFICANT), Amgen(SIGNIFICANT), Bristol-Myers Squibb(SIGNIFICANT), Cardinal Health(SIGNIFICANT), Eli Lilly and Company(SIGNIFICANT), Teva Pharmaceuticals(MODEST), Singulex(SIGNIFICANT), Pfizer(SIGNIFICANT), Mylan Laboratories(MODEST), Merck(SIGNIFICANT), General Electric(MODEST), Medtronic(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Siemens(SIGNIFICANT), INVIA Medical Imaging Solutions(SIGNIFICANT)